Vicky Boake
|Subscribers
About
Metandienone Wikipedia
Short answer
> If you’re asking whether tamoxifen (the drug used in breast‑cancer treatment and prevention) is worth taking, the decision depends on your personal risk of recurrence or new cancer versus the side‑effects you’re willing to tolerate.
>
> 1. High risk (e.g., early‑stage ER‑positive breast cancer that has not yet recurred, strong family history, BRCA mutation, etc.) → tamoxifen is usually recommended and can reduce recurrence or new‑cancer risk by ~40–50 %.
>
> 2. Moderate/low risk (e.g., no prior breast cancer, only a few risk factors) → the benefit may be small; you might choose to forego it or consider an alternative like aromatase inhibitors in post‑menopausal women.
If you’re referring to something else—like a different drug or a non‑medical use—please clarify and I’ll give a more specific answer.
